Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Not applicableNo Longer AvailableNCT02822495What this trial is testingExpanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or MalignanciesWho this might be right forEpstein-Barr Virus (EBV) InfectionsLymphoproliferative DisordersEBV+ Associated Lymphoma+9 more Atara Biotherapeutics
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT05166577What this trial is testingNanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPCWho this might be right forNasopharyngeal CarcinomaEBV-Related Gastric CarcinomaEBV-Related Leiomyosarcoma+2 more Viracta Therapeutics, Inc. 26
Not applicableWithdrawnNCT00378781What this trial is testingHeparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionWho this might be right forCancer M.D. Anderson Cancer Center